SC262

· Sana Biotechnology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SC262, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) [Phase 1]